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Aggregation of the high-afﬁnity IgE receptor (FcεRI) initiates a cascade of signaling events
leading to release of preformed inﬂammatory and allergy mediators and de novo synthesis
and secretion of cytokines and other compounds.The ﬁrst biochemically well deﬁned step
of this signaling cascade is tyrosine phosphorylation of the FcεRI subunits by Src family
kinase Lyn, followed by recruitment and activation of spleen tyrosine kinase (Syk). Activity
of Syk is decisive for the formation of multicomponent signaling assemblies, the signalo-
somes, in the vicinity of the receptors. Formation of the signalosomes is dependent on
the presence of transmembrane adaptor proteins (TRAPs). These proteins are character-
ized by a short extracellular domain, a single transmembrane domain, and a cytoplasmic
tail with various motifs serving as anchors for cytoplasmic signaling molecules. In mast
cells ﬁve TRAPs have been identiﬁed [linker for activation of T cells (LAT), non-T cell acti-
vation linker (NTAL), linker for activation of X cells (LAX), phosphoprotein associated with
glycosphingolipid-enriched membrane microdomains (PAG), and growth factor receptor-
bound protein 2 (Grb2)-binding adaptor protein, transmembrane (GAPT)]; engagement of
four of them (LAT, NTAL, LAX, and PAG) in FcεRI signaling has been documented. Here we
discuss recent progress in the understanding of how TRAPs affect FcεRI-mediated mast
cell signaling.The combined data indicate that individualTRAPs have irreplaceable roles in
important signaling events such as calcium response, degranulation, cytokines production,
and chemotaxis.
Keywords: mast cells, IgE receptor, plasma membrane, transmembrane adaptor proteins, LAT/LAT1,
NTAL/Lab/LAT2, LAX, PAG/Cbp
INTRODUCTION
Activation through the high-afﬁnity IgE receptor (FcεRI) and
other immunoreceptors is characterized by formation of multi-
protein signaling assemblies (signalosomes) on the cytoplasmic
sideof theplasmamembrane.Theinitialwellcharacterizedstepin
this process is phosphorylation of the immunoreceptor tyrosine-
based activation motifs (ITAMs) in the cytoplasmic tails of the
FcεRIβandγsubunitsbySrcfamilyproteintyrosinekinase(PTK)
Lyn (Eiseman and Bolen, 1992; Yamashita et al., 1994). Although
the exact molecular events preceding this activation step are not
completely clear, several models of the action mechanism have
been proposed, including the transphosphorylation model (Pri-
bluda et al.,1994),the lipid raft model (Field et al.,1995),and the
PTK–protein tyrosine phosphatase (PTP) interplay model (Buga-
jev et al., 2010; Heneberg et al., 2010). Tyrosine-phosphorylated
ITAMs of the FcεRI γ subunits serve as docking sites for the tan-
dem Src homology (SH)2 domains of the non-receptor tyrosine
kinase spleen tyrosine kinase (Syk) of the Syk/Zap-70 family. Syk
bound to ITAMs adopts an active conformation, facilitating its
phosphorylationbyLynandfurtherincreaseinenzymaticactivity.
Consequently, Syk phosphorylates a number of its targets critical
for further propagation of the signal, including transmembrane
adaptor proteins (TRAPs; see below), SH2 domain-containing
leukocyte phosphoprotein of 76kDa (SLP-76; Bubeck et al.,1996;
Hendricks-Taylor et al., 1997), phospholipase C (PLC)γ (Yablon-
ski et al., 2001), and p85 (Shim et al., 2004). The SLP-76 and
some other signaling molecules are constitutively bound to small
linker molecules growth factor receptor-bound protein 2 (Grb2)
or Grb2-related adaptor downstream of Shc (Gads). These linker
proteins posses two SH3 domains surrounding an SH2 domain.
The SH3 domains serve for constitutive binding to SLP-76 and
other proteins with proline-rich domains, whereas SH2 domains
bind to tyrosine-phosphorylated motifs on the TRAPs.
Transmembrane adaptor proteins serve as plasma membrane
docking sites for cytoplasmic signaling molecules, or as anchors
of cytoskeletal components to the plasma membrane. TRAPs are
characterized by a short extracellular domain,a single transmem-
branedomain,andacytoplasmictail,whichhasnointrinsicenzy-
matic activity but possesses various tyrosine-containing motifs
and domains. Extracellular domains are composed of only few
amino acids and are therefore unlikely to function as receptors
for extracellular ligands. The properties of the transmembrane
domains and the presence or absence of juxtamembrane palmi-
toylation motif, CXXC, determine the solubility of TRAPs in
non-ionic detergents, distribution in the plasma membrane, and
some other functional properties. Individual tyrosine residues in
the cytoplasmic tail of the TRAPs are initially phosphorylated by
PTKs of the Src and/or Syk/Zap-70 families and contribute to the
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functionof theTRAPsasmolecularscaffoldsrecruitingthedown-
stream effector proteins. Five TRAPs have been identiﬁed in mast
cells: linker for activation of T cells (LAT), non-T cell activation
linker(NTAL),linkerforactivationof Xcells(LAX,Xindicates“to
be deﬁned”), phosphoprotein associated with glycosphingolipid-
enriched membrane microdomains (GEMs) (PAG), and Grb2-
bindingadaptorprotein,transmembrane(GAPT).Severalreviews
have been published on structural and functional properties of
TRAPsinimmunoreceptorsignaling(Horejšíetal.,2004;Gilﬁllan
andTkaczyk,2006;Simeonietal.,2008;Alvarez-Erricoetal.,2009;
FullerandZhang,2009;Balagopalanetal.,2010;Fulleretal.,2011).
Here we focus on more recent advances from studies examining
the role of TRAPs in FcεRI signaling.
LINKER FOR ACTIVATION OF T CELLS
ThisTRAP,alsotermedLAT1,wasinitiallydetectedasaprominent
36–38kDa tyrosine-phosphorylated protein occurring as a conse-
quenceoftheTcellreceptor(TCR)engagement(Juneetal.,1990).
Later it was cloned (Weber et al., 1998; Zhang et al., 1998a) and
found to be expressed in several cell types,including natural killer
(NK) cells, megakaryocytes, platelets, immature B cells, and mast
cells (Facchettietal.,1999;Oyaetal.,2003).Otherstudiesshowed
that LAT could be phosphorylated by Syk or ZAP-70, depending
on the cell type studied, and that phosphorylated LAT associated
directly or indirectly with numerous signaling molecules such as
Grb2,PLCγ1,guaninenucleotideexchangefactorVav,Cbl,SLP-76,
andGads(Gillilandetal.,1992;Budayetal.,1994;Siehetal.,1994;
Trub et al., 1997; Finco et al., 1998; Zhang et al., 1998a; Liu et al.,
1999; Ishiai et al.,2000). LAT is one of the most important TRAPs
in immunoreceptor signaling. Sequencing of human, mouse, and
rat LAT cDNA revealed an open reading frame encoding, respec-
tively,233,242,and 241 amino acid-containing proteins. As other
TRAPs,LATpossessesaveryshortextracellularregion(fouramino
acids), a single transmembrane spanning domain, and a long
cytoplasmic region without any intrinsic enzymatic activity, but
containing various motifs (Figure 1). The cytoplasmic domain
possesses nine tyrosine residues conserved in humans, mice, and
rats,of whichﬁvecanbephosphorylatedandserveasbindingsites
for SH2 domain-containing proteins (Paz et al., 2001; Zhu et al.,
2003). There are also two conserved cysteine residues, located in
the vicinity of the transmembrane domain, which are the sub-
ject of post-translational palmitoylation (Zhang et al., 1998b).
Two potential ubiquitylation sites (K52 and K204 in human LAT)
might be involved in the regulation of LAT protein levels and
internalization of LAT complexes (Balagopalan et al., 2011).
In FcεRI-activated mast cells LAT becomes rapidly phosphory-
lated with peak reaching 2min after triggering. In mice deﬁcient
in LAT, the development of mast cells was not affected (Saitoh
et al., 2000), in contrast to development of T cells (Zhang et al.,
1999),but the animals were resistant to IgE-mediated passive sys-
temic anaphylaxis. This suggests that function of mast cells in
LAT−/− mice is compromised. Differentiation of mast cells from
bone marrow precursors under in vitro conditions was unaffected
by the absence of LAT,but activation of the bone marrow-derived
mast cells (BMMCs), manifested as tyrosine phosphorylation
of numerous substrates, mobilization of intracellular calcium,
degranulation, and transcription of several cytokine genes was
markedly impaired. However,inhibition was incomplete,suggest-
ing that some other TRAPs could also be involved (see Figure 2
andbelow).Antigen-inducedearlyactivationevents,suchastyro-
sine phosphorylation of the FcεRI β and γ subunits as well as
tyrosine phosphorylation of Syk were not affected by the absence
of LAT, which is in line with ﬁndings that LAT is a substrate for
Syk. In contrast, LAT distal events, like tyrosine phosphorylation
of PLCγ1,PLCγ2,andSLP-76,weremarkedlyinhibitedinLAT−/−
BMMCs.
BasedonthestudieswithLATmutantstransfectedintoLAT−/−
BMMCs, it was concluded that the most important tyrosine
in human and mouse LAT is the Y132 and Y136, respectively
(Figure 1). This tyrosine is found in motif YLVV, which consti-
tutesamajordockingsiteforPLCγ1;mostPLCγ1-dependentsteps
are therefore inhibited in mouse cells with LAT mutated at Y136
(Saitoh et al., 2003). The activity of PLCγ1 was also inhibited in
someothermutantsdeﬁcientinGrb2-bindingmotifs.Thiscanbe
explained by involvement of Grb2 in PLCγ1–LAT interactions.
Further studies showed that combinations of mutants in LAT
tyrosines(ﬁveproximalandfourdistal)resultedinbothdecreased
and increased degranulation and cytokines production, depend-
ing on the tyrosine(-s) mutated. These data support the concept
that LAT could regulate FcεRI signaling not only positively, but
also negatively (Malbec et al., 2004). Negative regulation of FcεRI
signaling seems to be mediated by the most distal tyrosine, which
provides a major binding site for SHIP1 (SH2 domain-containing
inositol 5-phosphatase; Roget et al., 2008). SHIP1 acts as potent
inhibitor of mast cell signaling by removing 5-phosphate groups
in the inositol ring of 3-phosphorylated inositides and phos-
phatidylinositides, and thus prevents membrane recruitment of
moleculescontainingpleckstrinhomologydomains(Scharenberg
et al., 1998). Furthermore, membrane bound SHIP1 negatively
regulatestheRaspathwaybyrecruitingDok-1andRasGAP(Tamir
et al.,2000).
Biochemical studies indicated that dually palmitoylated LAT is
localized in plasma membrane microdomains resistant to solubi-
lization by non-ionic detergents (Zhang et al., 1998b). This was
taken as evidence that LAT is a marker of lipid rafts. In contrast,
FcεRI in quiescent cells is detergent soluble, a fact suggesting that
it is localized outside lipid rafts. After aggregation, FcεRI became
detergent insoluble, strengthening thus the concept that antigen-
inducedmastcellsignalingisinitiatedbyamovementofFcεRIinto
lipid rafts (as assumed by the lipid raft model mentioned above),
whereitisphosphorylatedbyLynkinaseconsideredtobeconstitu-
tively associated with lipid rafts. However, immunogold electron
microscopy studies on isolated plasma membrane sheets failed
to bring direct evidence supporting the notion that aggregated
FcεRI and LAT are located in the same membrane compart-
ments. In fact, LAT-containing plasma membrane microdomains
and FcεRI-containing domains were separated before activation
and remained separated after activation, even though they were
enlarged in size (Wilson et al., 2002, 2004; Lebduška et al., 2007;
Carroll-Portillo et al.,2010). Molecular basis of this segregation is
unclear, though it could provide a basis for short “kiss-and-run”
interactions of FcεRI-anchored Syk and its substrate, LAT. Such
interactions could be preferable for the transient nature of FcεRI
signaling. Contrary to that,prolonged interaction of Syk and LAT
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FIGURE1|S c hematic illustration ofTRAPs studied in human and
mouse mast cells. All ﬁveTRAPs are characterized by a short
extracellular domain, a transmembrane domain, and a cytoplasmic
domain with various motifs. LAT, NTAL, and PAG possess
juxtamembrane CxxC palmitoylation site for their interactions with lipids
and localization in detergent-resistant membranes. AllTRAPs have
various tyrosine-based motifs which after phosphorylation serve as
binding sites for the indicated SH2-containing proteins. PAG also
contains proline-rich domains serving as anchor for SH3-containing
proteins. Number of amino acids (AA) in eachTRAP as well as accession
numbers in the GenBank sequence database provided by National
Center for Biotechnology Information (NCBI) are also shown.
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FIGURE2|F c εRI signaling events inWT, NTAL
−/−, and LAT
−/− cells. In
WT cells expressing both NTAL and LAT, aggregation of the receptors by
multivalent antigen leads to rapid Lyn kinase-mediated phosphorylation of
tyrosine residues in ITAM motifs of FcεRI β and γ subunits, followed by
anchor of Syk to FcεRI through interaction of Syk SH2 domains with
phosphorylated ITAMs. Syk then phosphorylates NTAL and LAT to create
binding sites for various SH2-containing proteins. Phosphorylated LAT
allows direct binding of SH2 domains of PLCγ1, Grb2, Gads, and SHIP1.
Grb2 and Gads serve as binding sites and stabilizers for other molecules
including SLP-76, VAV, and SOS. Activity of PLCγ1 leads to enhanced
production of IP3 and DAG, followed by increased Ca
2+ inﬂux, degranulation,
and production of transcription factors. Phosphorylated NTAL also binds
Grb2 and some other signaling proteins, except for PLCγ1. However, even in
the absence of binding to PLCγ1, NTAL can modulate Ca
2+ signaling,
degranulation, and cell survival through indirect cross-talk with PI3 activation
pathway. In activated NTAL
−/− cells, an important Syk substrate (NTAL) is
missing and LAT is therefore more phosphorylated.This leads to enhanced
binding and activity of PLCγ1 and all subsequent PLCγ-dependent events.
However, NTAL-dependent activity of Akt is impaired and this could lead to
decreased cell survival. In activated LAT
−/− cells, decreased Ca
2+ inﬂux,
degranulation, and production of transcription factors are due to the
absence of PLCγ1 anchored to LAT.The remaining weak Ca
2+ response,
degranulation and production of transcription factors is based on
NTAL -mediated activation events.
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inmixeddomainscontainingbothLATandFcεRI(withSyk)could
provide more stable structures (“kiss-and-stick”) which would be
more difﬁcult to regulate by phosphatases and other regulatory
molecules. Similarly,most of Lyn–FcεRI interactions are transient
(Oliver et al.,2000).
NON-T CELL ACTIVATION LINKER
This adaptor protein, also termed linker for activation of B cells
(LAB)orLAT2,wasﬁrstidentiﬁedinmyeloidcelllinesHL-60and
THP-1 as a 30-kDa phosphorylated protein not detectable in T
cells (Brdicka et al., 2002). In parallel, this TRAP was also discov-
ered by search in human genome database for molecules with ﬁve
Grb2-binding motifs (YXN, where X stands for any amino acid),
putative transmembrane domain with a stretch of hydrophobic
residues and potential palmitoylation sites (Janssen et al., 2003).
NTALisexpressedmainlyinBcells,NKcells,monocytes,andmast
cells, but not in quiescent T cells. Although NTAL has structural
features similar to LAT (Figure 1), there is no major homology
in amino acid sequences between these two adaptors. NTAL pos-
sesses10tyrosineswithinthecytosolictail;ﬁveof themwithinthe
putative Grb2-binding sites and one within the putative SHP1/Src
kinase-bindingsite(YIDP).IncontrasttoLAT,NTALislackingthe
PLCγ1 binding motif. In cells activated through FcεRI,NTAL was
rapidly phosphorylated by Syk and Lyn kinase. Interestingly,these
kinases produced entirely different pattern of phosphorylation of
the individual tyrosines (Iwaki et al.,2008).
Experiments in vivo showed that mice with NTAL knock-out
exhibited signiﬁcantly enhanced passive systematic anaphylaxis;
this implies that NTAL has a negative regulatory role in mast
cells signaling (Volná et al.,2004). This conclusion was conﬁrmed
by in vitro studies comparing the properties of antigen-activated
BMMCs derived from NTAL-deﬁcient or WT mice. NTAL−/−
cells exhibited enhanced phosphorylation of LAT, PLCγ1, PLCγ2,
extracellular signal-regulated kinase (Erk), calcium mobilization,
degranulation, cytokines production, and enzymatic activity of
inositol 1,4,5-trisphosphate (Figure 2,N T A L −/−). Interestingly,
mast cells lacking both LAT and NTAL exhibited a stronger block
in FcεRI signaling than LAT−/− mast cells, demonstrating again
that NTAL could play both positive and negative roles in FcεRI
signaling (Volná et al.,2004; Zhu et al., 2004).
All above mentioned data were obtained in experiments with
mouse-derived mast cells. However, when human mast cells with
decreased NTAL expression were analyzed, impaired degranula-
tion was observed, indicating prevalence of positive regulation
of NTAL in that system (Tkaczyk et al., 2004). The observed
difference between human and mouse mast cells could reﬂect
qualitativelyorquantitativelydifferentmolecularcontextinwhich
these molecules operate. Furthermore, there were differences in
methodsusedforNTALsilencing.Mousemastcellswereobtained
from animals lacking NTAL by genetic knock-out. It is possi-
ble that compensatory mechanisms during mouse development
led to quantitative or qualitative “compensatory” changes in the
expression of some other signaling molecules. On the other hand,
in experiments with human mast cells, NTAL was silenced only
partially (by ∼72%) by exposing the cells to NTAL-speciﬁc small
interfering (si)RNA, and tests were performed 64h later. In this
case, compensatory mechanisms are unlikely to play any major
role. Although it is not clear what causes the different outcome
of NTAL silencing in mouse and human mast cells, the com-
bined data indicate that NTAL exerts both positive and neg-
ative regulatory roles on FcεRI signaling, and reﬂect thus the
complex nature of regulatory factors involved in this signaling
pathway.
Recent studies by Koretzky and collaborators on mouse
BMMCs deﬁcient in LAT and/or NTAL showed that these two
adaptors bind cytoplasmic adapter molecule SLP-76 via Gads
(Kambayashi et al., 2010). Although NTAL supported SLP-76
phosphorylation and its recruitment to the plasma membrane,
NTAL only partially compensated for LAT-mediated signaling
events. This is attributable to decreased stability of NTAL–
GADS/SLP-76–PLCγ interactions. Since tyrosine phosphoryla-
tion of SLP-76 was not completely lost in LAT and NTAL
double-deﬁcient cells, it suggests that other TRAPs, such as LAX
(see below) could be involved in SLP-76 anchor to the plasma
membrane.
In spite of the similarity in their mode of anchor to the plasma
membraneandpoorsolubilityinnon-ionicdetergents,NTALand
LAT occupy different membrane microdomains. This was deter-
mined by immunogold electron microscopy studies on isolated
plasma membrane sheets from non-activated and FcεRI-activated
cells (Figure3;Volná et al.,2004;Heneberg et al.,2006). The mol-
ecular basis of the observed topographical differences is unknown
but could possibly be related to regulatory mechanisms based on
space separation (see discussion above).
Non-T cell activation linker is also involved in the regula-
tion of cell morphology and cell–substrate interactions. Studies
with rat basophilic leukemia (RBL) cells transfected with NTAL
cDNA showed that the cells expressing more NTAL adhered less
efﬁciently to tissue culture plastic, and exhibited more rounded
shapes and less developed processes than parental RBL cells.
On the contrary, RBL cells with a decreased amount of NTAL
(obtained after transfection of NTAL-speciﬁc hairpin siRNA),
showed fewer but more developed processes. The observed
changes in cellular morphology were apparently caused by dif-
ferences in the function and/or regulation of actin cytoskeleton
network. An indirect support for this conclusion is observa-
tion of an enhanced amount of ﬁlamentous (F)-actin in NTAL-
deﬁcient cells and a decreased amount of F-actin in NTAL
overexpressors (Dráberová et al., 2007). Other studies showed
that FcεRI-activated BMMCs from NTAL-deﬁcient mice, in con-
trast to cells from WT mice, exhibited reduced spreading on
ﬁbronectin (Figure 4), but enhanced F-actin depolymerization
(Tumová et al., 2010). This probably relates to the decrease
in RhoA activity, which is deeper in NTAL−/− cells than WT
cells. Interestingly, spreading on ﬁbronectin after exposure to
stem cell factor (SCF) was similar in WT and NTAL−/− cells
(Figure4).Thisindicatesthatchemotaxisinducedbyengagement
of FcεRI or c-kit uses, respectively, NTAL-dependent or NTAL-
independent signaling pathways. The important role of NTAL
in FcεRI-induced formation of F-actin assemblies was conﬁrmed
by experiments where defects in both cell spreading and actin
polymerization/depolymerization status in NTAL−/− cells were
restoredaftertransfectionofNTAL–GFPconstruct(Tumováetal.,
2010).
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FIGURE 3 | Non-T cell activation linker, LAT, and FcεRI occupy different
membrane microdomains in non-activated and FcεRI-activated cells.
Plasma membrane sheets were isolated from non-activated (A,C,E) or
antigen-activated (B,D,F) RBL -2H3 cells and double-labeled from the
cytoplasmic side with ﬁrst layer antibodies speciﬁc for the target structures
and second layer anti-antibodies labeled with 5 or 10nm gold particles. (A,B)
FcεRI β subunit labeled with 10nm gold (arrows) and NTAL labeled with 5nm
gold (arrowheads). (C,D) FcεRI β subunit labeled with 10nm gold (arrows) and
LAT labeled with 5nm gold (arrowheads). (E,F) LAT labeled with 10nm gold
(arrows) and NTAL labeled with 5nm gold (arrowheads). Scale bar in (D),
100nm. Originally published in Journal of Experimental Medicine (Volná et al.,
2004) where all experimental procedure details have been described.
Non-Tcellactivationlinkerisalsolikelytoplayanegativeregu-
latory role in FcεRI-mediated chemotaxis,since migration toward
antigenwasgreaterinNTAL−/− cellsthanWTcells.Inaccordance
with studies on cell spreading, the absence of NTAL had no dra-
matic effect on migration toward SCF (Tumová et al., 2010). The
combined data suggest that the cross-talk between NTAL and
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FIGURE 4 | Non-T cell activation linker positively regulates spreading
on ﬁbronectin in BMMCs activated via FcεRI but not via SCF.
(A) IgE-sensitized WT cells or NTAL
−/− cells were activated for 20min with
antigen or SCF , ﬁxed and stained for F-actin with phalloidin-Alexa Fluor 488
conjugate.The images are confocal micrographs taken at equatorial planes.
Scale bar, 20μm. (B) WT cells (full line) or NTAL
−/− cells (dotted line) were
activated with antigen or SCF for the indicated time intervals, ﬁxed and
stained for F-actin as in (A). Proportion of spread cells was calculated from
>200 cells evaluated at each time interval. Means and SE were calculated
from two (5min) or ﬁve (20 and 30min) independent experiments.
Signiﬁcance of differences at given times between WT and NTAL
−/− cells is
also shown (*p <0.05; **p <0.005; Student’s t-test). Originally published
in European Journal of Immunology (Tumová et al., 2010) where all
experimental procedure details have been described.
RhoA has a crucial role in the regulation of actin cytoskeleton
dynamics in FcεRI-activated cells.
Theexactmolecularmechanismof NTAL-dependentsignaling
in activated mast cells is not known, and several hypotheses are
conceivable. First, increased phosphorylation of LAT in FcεRI-
activated NTAL−/− cells is accompanied by enhanced binding
of PLCγ1 and PLCγ2 to LAT, followed by increased tyrosine
phosphorylation of these enzymes and,consequently,higher pro-
duction of Ca2+ and degranulation. We have speculated that
enhanced LAT phosphorylation in NTAL−/− cells may be caused
by a decreased competition for Syk between LAT and NTAL
(Volná et al., 2004; Figure 2). Second, it has been demonstrated
that Ca2+ response is higher in NTAL−/− cells than in WT cells
even after stimulation with thapsigargin, an agent that induces
the release of Ca2+ from intracellular stores by inhibiting the
endoplasmic reticulum ATPase (Thastrup et al., 1989). This drug
acts directly on the Ca2+ pump, and LAT and NTAL phos-
phorylation steps are thus bypassed. Noteworthy, dramatically
increased levels of cytoplasmic Ca2+ were observed in experi-
ments with Ca2+-containing media, but not in Ca2+-free media.
This implies that Ca2+ inﬂux plays a major role. Direct analy-
sis of 45Ca inﬂux into the cells has conﬁrmed that NTAL could
regulate the Ca2+ uptake in the absence of its detectable phos-
phorylation. Based on these and other experimental results we
have proposed that NTAL could regulate the activity of Ca2+
channels at the level of plasma membrane by direct or indirect
interactions with Ca2+ channel components (Dráberová et al.,
2007) or that it somehow interacts with store operated Ca2+
entry (SOCE) regulators, such as stromal interaction molecule 1
(STIM1; Dráber and Dráberová, 2005). Third, NTAL could posi-
tively regulate mast cell activation and survival by the recruitment
of SHIP1, and thus decreasing binding of this phosphatase to
LAT (Roget et al., 2008). In this connection it should be men-
tioned that NTAL and LAT also regulate mast cells survival in the
absence of IL-3 by a pathway involving Erk and Ras (Yamasaki
et al., 2007; Roget et al., 2008). In BMMCs derived from mice
deﬁcient in both NTAL and LAT, activation of Erk and Ras was
inhibited, and the survival in the absence of IL-3 was impaired.
Survival of NTAL−/−/LAT−/− cells was restored to WT level
by membrane-targeted Sos, which bypassed the Grb2-mediated
membrane recruitment of Sos. The data suggest that NTAL and
LAT improve cell survival through membrane retention of the
Ras-activating complex Grb2–Sos.
LINKER FOR ACTIVATION OF X CELLS
The LAX adaptor has been discovered when searching the human
genome database for tyrosine motifs found in LAT (Zhu et al.,
2002). Translation of human and mouse LAX cDNA revealed that
LAX gene encodes a putative protein of 398 residues and 407
residues, respectively (Figure 1). Five of the 10 tyrosines in cyto-
plasmic tail of human LAX are within the Grb2-binding motifs.
It also has a Gads motif (YVNV) identical to that in LAT, and
a p85-binding motif (YXXM) which is missing in LAT. In con-
trast to LAT and NTAL, LAX lacks the submembranous CXXC
palmitoylationmotif;thisexplainsitssolubilityinnon-ionicdeter-
gents. In activated cells, LAX is tyrosine-phosphorylated by Src
and Syk/Zap-70 family kinases. As shown by transfection studies,
defectivesignalinginLAT-deﬁcientJurkatTcellscouldberescued
by expression of LAT but not LAX. LAX was also found expressed
in mast cells. Aggregation of the FcεRI in LAX-deﬁcient BMMCs
resulted in enhanced phosphorylation of LAT, activation of p38
MAPK and PI3 kinase, degranulation, cytokines production, and
cell survival. The data suggest that LAX plays an important role in
mast cell function through negative regulation of PI3K pathway.
Although mast cells derived from LAX-deﬁcient mice exhibited
in vitro an enhanced responsiveness after FcεRI triggering, IgE-
dependent systemic anaphylaxis in vivo was comparable between
LAX−/− and WT mice. One explanation for this observation is a
higher basal level of IgE in LAX−/− mice compared to WT mice,
and a competition between exogenous antigen-speciﬁc IgE with
endogenous IgE for surface receptors of target cells (Zhu et al.,
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2006).TheexpressionofNTALinbothnon-activatedandantigen-
activated BMMCs was signiﬁcantly lower in LAX−/− cells than it
was in WT cells. It is therefore possible that at least some of the
observed changes in LAX-deﬁcient cells reﬂect the changed ratio
between LAT and NTAL in favor of LAT. The molecular basis
for the observed decrease of NTAL in LAX-deﬁcient cells remains
hitherto unknown. Better understanding of the problem could
bringexperimentscomparingpropertiesof WTcellswiththecells
in which LAX expression is decreased by siRNAs. Furthermore,
studies based on the whole genome transcriptional analysis from
WT cells and LAX-deﬁcient cells could be informative.
PHOSPHOPROTEIN ASSOCIATED WITH
GLYCOSPHINGOLIPID-ENRICHED MEMBRANE
MICRODOMAINS
This protein, also termed Csk-binding protein (Cbp), was ﬁrst
described in 2000 in two studies analyzing (1) a GEMs-associated
tyrosine-phosphorylated protein of 80kDa in cell line Raji
(Brdicka et al., 2000) and (2) Csk co-precipitating protein of 80–
90kDa from neonatal rat brain (Kawabuchi et al., 2000). Like
other TRAPs, PAG has a short extracellular domain (16 amino
acids), a transmembrane domain followed by palmitoylation site,
andacytoplasmictailcontaining10tyrosines.Furthermore,ithas
two proline-rich sequences which serve as binding sites for SH3
domains. PAG is a substrate for Lck and Fyn but not for Zap-70 or
Syk.PAGphosphorylatedontyrosine317(human)ortyrosine314
(mouse) binds Csk. Based on the initial studies, it was postulated
that Csk binds via its SH2 domain to tyrosine-phosphorylated
PAG. Membrane anchored Csk then phosphorylates C-terminal
tyrosines of Src family kinases in the vicinity of PAG, and inacti-
vatestheminthisway.InTcells,activationthroughtheTCRleads
to a rapid PAG dephosphorylation, which results in the release of
Csk from the membrane and relief of Csk-mediated inhibition of
Src kinases.
In mast cells, PAG is differently phosphorylated during FcεRI
signaling(Ohtakeetal.,2002).Antigen-inducedaggregationofthe
FcεRI in RBL cells resulted in a rapid increase in tyrosine phos-
phorylation of PAG and its association with Csk. In an attempt to
elucidate the role of PAG in FcεRI-mediated signaling, PAG was
over-expressed in RBL cells and their activation was assessed. As
expected,FcεRI-activatedcellswithenhancedlevelsof PAGexhib-
iteddecreasedtyrosinephosphorylationofFcεRIβandγsubunits,
lowerdegranulation,andreducedcalciumresponseindicatingthat
PAGisanegativeregulatorof FcεRIsignalinginRBLcells. In vitro
kinase assays showed that over-expression of PAG inhibited the
increase of FcεRI-associated kinase activity induced by antigen
stimulation. These data together with the ﬁnding that tyrosine
phosphorylation of PAG is inhibited by Src-speciﬁc inhibitor PP2
can be taken as evidence that PAG negatively regulates the acti-
vation of FcεRI-bound PTKs, and serves as a negative feedback
regulator for FcεRI signaling.
The described regulatory mechanism was corroborated by
studies of BMMCs cells from epilepsy-prone (EL) and epilepsy-
resistant (ASK) mice (Kitaura et al., 2007). The authors found
that ASK mice exhibited reduced Lyn activity and consequently
reduced tyrosine phosphorylation of Cbp/PAG, combined with
enhanced production of TNF-α and IL-2. The data support the
notion that activation of Lyn leads to enhanced phosphorylation
ofPAG,followedbyrecruitmentofCsktoCbp/PAGandinhibition
of Src family kinases localized in the same membrane domains.
GRB2-BINDING ADAPTOR PROTEIN, TRANSMEMBRANE
The GAPT was discovered by in silico screening for novel TRAPs
in human genome database (Liu and Zhang, 2008). This pro-
tein contains seven tyrosine residues in its cytosolic region; four
of them within a Grb2-binding motif (Figure 1). Immunoblot-
ting analysis showed that GAPT is expressed primarily in murine
B220+ spleen cells and total bone marrow cells. It was found less
expressed in dendritic cells and mast cells, and was absent in T
cells and macrophages. When bone marrow cells from WT mice
or mice deﬁcient in GAPT were cultured in the presence of IL-3,
similar numbers of BMMCs were observed after 3weeks in cul-
ture.Furthermore,aggregationofFcεRIinGAPT+/+ orGAPT−/−
BMMCsresultedincomparabledegranulation.Thesedataseemto
indicatethatGAPTisnotrequiredforBMMCsdifferentiationand
FcεRI-mediatedactivation.IncontrasttoLATandNTAL,GAPTis
notphosphorylatedontyrosineafterFcεRItriggering.However,it
remains to be determined whether GAPT is phosphorylated after
engagement of other receptors. Likewise,the function of GAPT in
migration and other assays has not yet been critically tested.
TRAPs IN OTHER FcεRI-EXPRESSING CELLS
FcεRIisabundantlyexpressednotonlyinhumanandrodentmast
cells, but also in basophils. These two cell types express FcεRI as
a heterotetramer containing one IgE binding subunit α,o n eβ
subunit and two γ subunits (αβγ2). FcεRI is also found in het-
erotrimeric form lacking the β chain (αγ2; Kinet, 1999). These
trimeric forms have been described in human Langerhans’cells
(Bieber et al., 1992; Wang et al., 1992), eosinophils (Gounni et al.,
1994), monocytes (Maurer et al., 1994), peripheral blood den-
dritic cells (Maurer et al.,1996),platelets (Joseph et al.,1997),and
pinealocytes (Ganguly et al., 2007). However, in some cell types
like human eosinophils the FcεRI is not expressed on the plasma
membrane and therefore is not involved in IgE receptor binding
and cell activation (Smith et al., 2000). Interestingly, mice lack
expression of αγ2 form of FcεRI and do not express the recep-
tor on cells other than mast cells and basophils. Information on
the function of TRAPs in FcεRI signaling in cells other than mast
cells is not available and there are only very limited data on the
expressionof TRAPsinbasophilsandotherFcεRI-expressingcells
(Ishmael and MacGlashan,2009).
CONCLUDING REMARKS
Five TRAPs have been characterized in mast cells and four of
them were found to be involved in FcεRI signaling. Apparently
the list is still not complete and other TRAPs will be found. For
exampleitisnotclearwhethermastcellsexpressarecentlydiscov-
ered TRAP composed of only 145 amino acids,the SLP65/SLP-76,
Csk interacting membrane protein (SCIMP; Draber et al., 2011).
This protein was detected when searching the databases for TRAP
motifs.InBcellsitistyrosine-phosphorylatedafterstimulationvia
the major histocompatibility complex II. Phosphorylated SCIMP
binds SH2 domains of SLP65/SLP-76 adaptor protein and Csk
andregulatesinthiswaythesignaltransductionafterMHCIItrig-
gering. Its role in mast cell development and FcεRI signaling has
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not been determined. Identiﬁcation of all TRAPs and their inter-
action partners involved in mast cell activation is the ﬁrst step
toward understanding the mast cell signaling pathways in their
complexities.
Transmembrane adaptor proteins are equipped for extensive
cross-talk not only with cytoplasmic signaling molecules,but also
with other highly dynamic components of the plasma mem-
brane. How plasma membrane-associated molecules are orga-
nized into functional domains/units in non-activated cells, as
well as their changes in the course of cell activation and partic-
ipation in signalosomes formation is another important set of
problems. For example, the molecular basis of different plasma
membrane topography of two similar TRAPs, namely NTAL and
LAT (see above), remains mysterious and the puzzle suggests
that different signalosomes could be formed in activated cells.
The minimal size of the signalosomes is another unanswered
question. Previous topographical data obtained with cells acti-
v a t e db yF c εRI-dimerizing monoclonal antibody suggested that
the size may be very small (Dráberová et al., 2004) and their
number could be therefore very high. Solution of these prob-
lems will require new methodologies, such as the real-time high-
resolution microscopy on live cells (Fernandez-Suarez and Ting,
2008).
Some of the TRAPs, such as GAPT, with no dramatic effect
on mast cell development and FcεRI signaling, might have their
role(s) masked by compensatory mechanisms. Analysis of mast
cells from animals with multiple gene knock-out or cells with
knock-downsof multipleproteinscouldthusbeveryinformative.
Also, studies based on conditional knock-out strategy combined
withinduciblesystems(Sauer,1998)orusingsiRNAprobesunder
in vivo conditions (Shim and Kwon, 2010) could have profound
impact on further understanding of the role TRAPs in mast cell
signaling. In addition, they might provide useful animal models
of mast cell diseases.
ACKNOWLEDGMENTS
Work on mast cell signaling in the laboratory of the authors
have been funded, over the years, by several projects, including
1M6837805001 (Center of Molecular and Cellular Immunology)
fromMinistryofEducation,YouthandSportsoftheCzechRepub-
lic, 301/09/1826 and P302/10/1759 from the Grant Agency of
the Czech Republic, KAN200520701, M200520901, and Institu-
tional project AVOZ50520514 from Academy of Sciences of the
Czech Republic. Part of this work was also supported by COST
ActionBM1007“MastCellsandBasophils–TargetsforInnovative
Therapies.”
REFERENCES
Alvarez-Errico, D., Lessmann, E., and
Rivera, J. (2009). Adapters in the
organization of mast cell signaling.
Immunol. Rev. 232, 195–217.
Balagopalan, L., Ashwell, B. A., Bernot,
K. M., Akpan, I. O., Quasba, N.,
Barr,V. A., and Samelson, L. (2011).
Enhanced T-cell signaling in cells
bearinglinkerforactivationofT-cell
(LAT)moleculesresistanttoubiqui-
tylation. Proc. Natl. Acad. Sci. U.S.A.
108, 2885–2890.
Balagopalan, L., Coussens, N. P., Sher-
man, E., Samelson, L. E., and Som-
mers, C. L. (2010). The LAT story:
a tale of cooperativity,coordination,
andchoreography.ColdSpringHarb.
Perspect. Biol. 2, a005512.
Bieber,T.,delaSalle,H.,Wollenberg,A.,
Hakimi, J., Chizzonite, R., Ring, J.,
Hanau,D.,anddelaSalle,C.(1992).
Human epidermal Langerhans cells
express the high afﬁnity receptor for
immunoglobulin E (FcεRI). J. Exp.
Med. 175, 1285–1290.
Brdicka, T., Imrich, M., Angelisová, P.,
Brdicková, N., Horváth, O., Špicka,
J., Hilgert, I., Lusková, P., Dráber, P.,
Novák, P., Engels, N., Wienands, J.,
Simeoni,L.,Österreicher,J.,Aguado,
E., Malissen, M., Schraven, B., and
Horejší, V. (2002). Non-T cell acti-
vation linker (NTAL): a transmem-
brane adaptor protein involved in
immunoreceptor signaling. J. Exp.
Med. 196, 1617–1626.
Brdicka, T., Pavlištová, D., Leo, A.,
Bruyns, E., Korínek, V., Angelisová,
P., Scherer, J., Shevchenko, A.,
Shevchenko,A.,Hilgert,I.,Cerný,J.,
Drbal, K., Kuramitsu, Y., Kornacker,
B., Horejší, V., and Schraven, B.
(2000). Phosphoprotein associated
with glycosphingolipid-enriched
microdomains (PAG), a novel ubiq-
uitously expressed transmembrane
adaptor protein, binds the protein
tyrosine kinase Csk and is involved
in regulation of T cell activation. J.
Exp. Med. 191, 1591–1604.
Bubeck, W. J., Fu, C., Jackman, J.
K., Flotow, H., Wilkinson, S. E.,
Williams, D. H., Johnson, R., Kong,
G., Chan, A. C., and Findell, P.
R. (1996). Phosphorylation of SLP-
76 by the ZAP-70 protein-tyrosine
kinase is required for T-cell recep-
tor function. J. Biol. Chem. 271,
19641–19644.
Buday, L., Egan, S. E., Rodriguez, V. P.,
Cantrell, D. A., and Downward, J.
(1994). A complex of Grb2 adaptor
protein, Sos exchange factor, and a
36-kDa membrane-bound tyrosine
phosphoprotein is implicated in ras
activation in T cells. J. Biol. Chem.
269, 9019–9023.
Bugajev, V., Bambousková, M.,
Dráberová, L., and Dráber, P.
(2010). What precedes the initial
tyrosine phosphorylation of the
highafﬁnityIgEreceptorinantigen-
activated mast cell? FEBS Lett. 584,
4949–4955.
Carroll-Portillo, A., Spendier, K., Pfeif-
fer, J., Grifﬁths, G., Li, H., Lidke, K.
A.,Oliver,J.M.,Lidke,D.S.,Thomas,
J. L., Wilson, B. S., and Timlin, J.
A. (2010). Formation of a mast cell
synapse:FcεRI membrane dynamics
upon binding mobile or immobi-
lizedligandsonsurfaces.J.Immunol.
184, 1328–1338.
Dráber, P., and Dráberová, L. (2005).
Lifting the fog in store-operated
Ca2+ entry. Trends Immunol. 26,
621–624.
Draber, P., Vonkova, I., Stepanek, O.,
Hrdinka, M., Kucova, M., Skopcova,
T., Otahal, P., Angelisova, P., Hore-
jsi, V., Yeung, M., Weiss, A., and
Brdicka, T. (2011). SCIMP, a trans-
membrane adaptor protein involved
inmajorhistocompatibilitycomplex
class II signaling. Mol. Cell Biol. 31,
4550–4562.
Dráberová, L., Lebduška, P., Hálová, I.,
Tolar, P., Štokrová, J., Tolarová, H.,
Korb, J., and Dráber, P. (2004). Sig-
naling assemblies formed in mast
cells activated via Fcε receptor
I dimers. Eur. J. Immunol. 34,
2209–2219.
Dráberová, L., Shaik, G. M., Volná, P.,
Heneberg,P.,Tumová,M.,Lebduška,
P., Korb, J., and Dráber, P. (2007).
RegulationofCa2+ signalinginmast
cells by tyrosine-phosphorylated
and unphosphorylated non-T cell
activation linker. J. Immunol. 179,
5169–5180.
Eiseman, E., and Bolen, J. B. (1992).
Engagement of the high-afﬁnity
IgE receptor activates src protein-
related tyrosine kinases. Nature 355,
78–80.
Facchetti, F., Chan, J. K., Zhang, W.,
Tironi, A., Chilosi, M., Parolini,
S., Notarangelo, L. D., and Samel-
son, L. E. (1999). Linker for acti-
vation of T cells (LAT), a novel
immunohistochemical marker for
T cells, NK cells, mast cells, and
megakaryocytes: evaluation in nor-
mal and pathological conditions.
Am. J. Pathol. 154, 1037–1046.
Fernandez-Suarez, M., and Ting, A.
Y. (2008). Fluorescent probes for
super-resolution imaging in living
cells. Nat. Rev. Mol. Cell Biol. 9,
929–943.
Field, K. A., Holowka, D., and Baird, B.
(1995).FcεRI-mediatedrecruitment
of p53/56lyn to detergent-resistant
membrane domains accompanies
cellular signaling. Proc. Natl. Acad.
Sci. U.S.A. 92, 9201–9205.
Finco, T. S., Kadlecek, T., Zhang,
W., Samelson, L. E., and Weiss,
A. (1998). LAT is required for
TCR-mediated activation of PLCγ1
and the Ras pathway. Immunity 9,
617–626.
Fuller, D. M., and Zhang, W. (2009).
Regulation of lymphocyte develop-
mentandactivationbytheLATfam-
ily of adapter proteins. Immunol.
Rev. 232, 72–83.
Fuller, D. M., Zhu, M., Ou-Yang, C. W.,
Sullivan,S.A.,andZhang,W.(2011).
A tale of two TRAPs: LAT and
LAB in the regulation of lympho-
cyte development, activation, and
autoimmunity. Immunol. Res. 49,
97–108.
www.frontiersin.org January 2012 | Volume 2 | Article 95 | 9Draber et al. TRAPs in FcεRI signaling
Ganguly, S., Grodzki, C., Sugden, D.,
Møller, M., Odom, S., Gaildrat, P.,
Gery, I., Siraganian, R. P., Rivera,
J., and Klein, D. C. (2007). Neural
adrenergic/cyclic AMP regulation
of the immunoglobulin E recep-
tor α-subunit expression in the
mammalian pinealocyte:a neuroen-
docrine/immune response link? J.
Biol. Chem. 282, 32758–32764.
Gilﬁllan, A. M., and Tkaczyk, C.
(2006). Integrated signalling path-
ways for mast-cell activation. Nat.
Rev. Immunol. 6, 218–230.
Gilliland, L. K., Schieven, G. L., Nor-
ris, N. A., Kanner, S. B., Aruffo, A.,
and Ledbetter, J. A. (1992). Lym-
phocyte lineage-restricted tyrosine-
phosphorylated proteins that bind
PLCγ1 SH2 domains. J. Biol. Chem.
267, 13610–13616.
Gounni, A. S., Lamkhioued, B., Ochiai,
K.,Tanaka,Y.,Delaporte,E.,Capron,
A., Kinet, J. P., and Capron, M.
(1994). High-afﬁnity IgE recep-
tor on eosinophils is involved in
defence against parasites. Nature
367, 183–186.
Hendricks-Taylor, L. R., Motto, D. G.,
Zhang, J., Siraganian, R. P., and
Koretzky, G. A. (1997). SLP-76 is
a substrate of the high afﬁnity IgE
receptor-stimulatedproteintyrosine
kinases in rat basophilic leukemia
cells. J. Biol. Chem. 272, 1363–1367.
Heneberg, P., Dráberová, L., Bam-
bousková, M., Pompach, P., and
Dráber, P. (2010). Down-regulation
of protein tyrosine phosphatases
activates an immune receptor in
the absence of its translocation
into lipid rafts. J. Biol. Chem. 285,
12787–12802.
Heneberg, P., Lebduška, P., Dráberová,
L., Korb, J., and Dráber, P. (2006).
Topography of plasma membrane
microdomains and its consequences
for mast cell signaling. Eur. J.
Immunol. 36, 2795–2806.
Horejší, V., Zhang, W., and Schraven,
B. (2004). Transmembrane adaptor
proteins: organizers of immunore-
ceptorsignalling.Nat.Rev.Immunol.
4, 603–616.
Ishiai,M.,Kurosaki,M.,Inabe,K.,Chan,
A.C.,Sugamura,K.,andKurosaki,T.
(2000). Involvement of LAT, Gads,
and Grb2 in compartmentation of
SLP-76 to the plasma membrane. J.
Exp. Med. 192, 847–856.
Ishmael, S., and MacGlashan, D. Jr.
(2009). Early signal protein expres-
sion proﬁles in basophils: a pop-
ulation study. J. Leukoc. Biol. 86,
313–325.
Iwaki, S., Spicka, J., Tkaczyk, C., Jensen,
B. M., Furumoto, Y., Charles, N.,
Kovarova, M., Rivera, J., Horejsi, V.,
Metcalfe, D. D., and Gilﬁllan, A.
M. (2008). Kit- and FcεRI-induced
differential phosphorylation of the
transmembrane adaptor molecule
NTAL/LAB/LAT2 allows ﬂexibility
in its scaffolding function in mast
cells. Cell. Signal. 20, 195–205.
Janssen, E., Zhu, M., Zhang, W., Koon-
paew,S.,andZhang,W.(2003).LAB:
anewmembrane-associatedadaptor
molecule in B cell activation. Nat.
Immunol. 4, 117–123.
Joseph, M., Gounni, A. S., Kusnierz, J.
P., Vorng, H., Sarfati, M., Kinet, J.
P., Tonnel, A. B., Capron, A., and
Capron, M. (1997). Expression and
functions of the high-afﬁnity IgE
receptor on human platelets and
megakaryocyte precursors. Eur. J.
Immunol. 27, 2212–2218.
June, C. H., Fletcher, M. C., Ledbetter,
J. A., and Samelson, L. E. (1990).
Increase in tyrosine phosphoryla-
tion are detectable before phospho-
lipase C activation after T cell recep-
tor stimulation. J. Immunol. 144,
1591–1599.
Kambayashi,T.,Okumura,M.,Baker,R.
G., Hsu, C. J., Baumgart, T., Zhang,
W.,andKoretzky,G.A.(2010).Inde-
pendent and cooperative roles of
adaptor molecules in proximal sig-
naling during FcεRI-mediated mast
cell activation. Mol. Cell Biol. 30,
4188–4196.
Kawabuchi, M., Satomi, Y., Takao, T.,
Shimonishi, Y., Nada, S., Nagai, K.,
Tarakhovsky, A., and Okada, M.
(2000). Transmembrane phospho-
protein Cbp regulates the activi-
ties of Src-family tyrosine kinases.
Nature 404, 999–1003.
Kinet,J. P. (1999). The high-afﬁnity IgE
receptor(FcεRI):fromphysiologyto
pathology. Annu. Rev. Immunol. 17,
931–972.
Kitaura, J., Kawakami, Y., Maeda-
Yamamoto, M., Horejsi, V., and
Kawakami, T. (2007). Dysregulation
of Src family kinases in mast cells
from epilepsy-resistant ASK versus
epilepsy-prone EL mice. J. Immunol.
178, 455–462.
Lebduška, P., Korb, J., Tumová, M.,
Heneberg, P., and Dráber, P. (2007).
Topography of signaling molecules
as detected by electron microscopy
on plasma membrane sheets iso-
lated from non-adherent mast
cells. J. Immunol. Methods 328,
139–151.
Liu, S. K., Fang, N., Koretzky, G. A.,
and McGlade, C. J. (1999). The
hematopoietic-speciﬁc adaptor pro-
tein gads functions in T-cell signal-
ing via interactions with the SLP-
76 and LAT adaptors. Curr. Biol. 9,
67–75.
Liu,Y.,andZhang,W.(2008).Identiﬁca-
tion of a new transmembrane adap-
tor protein that constitutively binds
Grb2 in B cells. J. Leukoc. Biol. 84,
842–851.
Malbec, O., Malissen, M., Isnardi, I.,
Lesourne,R.,Mura,A.-M.,Fridman,
W. H., Malissen, B., and Daëron, M.
(2004). Linker for activation of T
cells integrates positive and negative
signaling in mast cells. J. Immunol.
173, 5086–5094.
Maurer, D., Fiebiger, E., Reininger, B.,
Wolff-Winiski, B., Jouvin, M. H.,
Kilgus, O., Kinet, J. P., and Stingl,
G. (1994). Expression of functional
high afﬁnity immunoglobulin E
receptors (FcεRI) on monocytes of
atopic individuals. J. Exp. Med. 179,
745–750.
Maurer, D., Fiebiger, S., Ebner, C.,
Reininger, B., Fischer, G. F., Wich-
las, S., Jouvin, M. H., Schmitt-
Egenolf, M., Kraft, D., Kinet, J.
P., and Stingl, G. (1996). Periph-
eral blood dendritic cells express
FcεRI as a complex composed of
FcεRIα- and FcεRIγ-chains and can
use this receptor for IgE-mediated
allergen presentation. J. Immunol.
157, 607–616.
Ohtake, H., Ichikawa, N., Okada,
M., and Yamashita, T. (2002).
Cutting edge: transmembrane
phosphoprotein Csk-binding pro-
tein/phosphoprotein associated
with glycosphingolipid-enriched
microdomains as a negative feed-
back regulator of mast cell signaling
through the FcεRI. J. Immunol. 168,
2087–2090.
Oliver, J. M., Kepley, C. L., Ortega,
E., and Wilson, B. S. (2000).
Immunologically mediated signal-
ing in basophils and mast cells:ﬁnd-
ing therapeutic targets for allergic
diseases in the human FcεR1 signal-
ing pathway. Immunopharmacology
48, 269–281.
Oya, K., Wang, J., Watanabe, Y., Koga,
R.,andWatanabe,T.(2003).Appear-
ance of the LAT protein at an early
stage of B-cell development and
its possible role. Immunology 109,
351–359.
Paz, P. E., Wang, S., Clarke, H., Lu,
X., Stokoe, D., and Abo, A. (2001).
Mapping the Zap-70 phosphoryla-
tion sites on LAT (linker for activa-
tion of T cells) required for recruit-
ment and activation of signalling
proteins in T cells. Biochem. J. 356,
461–471.
Pribluda, V. S., Pribluda, C., and Met-
zger, H. (1994). Transphosphoryla-
tion as the mechanism by which
the high-afﬁnity receptor for IgE is
phosphorylated upon aggregation.
Proc. Natl. Acad. Sci. U.S.A. 91,
11246–11250.
Roget, K., Malissen, M., Malbec, O.,
Malissen,B.,andDaëron,M.(2008).
Non-T cell activation linker pro-
motes mast cell survival by damp-
ening the recruitment of SHIP1 by
linker for activation of T Cells. J.
Immunol. 180, 3689–3698.
Saitoh, S., Arudchandran, R., Manetz,
T. S., Zhang, W., Sommers, C. L.,
Love, P. E., Rivera, J., and Samel-
son,L. E. (2000). LAT is essential for
FcεRI-mediatedmastcellactivation.
Immunity 12, 525–535.
Saitoh,S.I.,Odom,S.,Gomez,G.,Som-
mers, C. L., Young, H. A., Rivera,
J., and Samelson, L. E. (2003). The
four distal tyrosines are required for
LAT-dependent signaling in FcεRI-
mediatedmastcellactivation.J.Exp.
Med. 198, 831–843.
Sauer, B. (1998). Inducible gene target-
inginmiceusingtheCre/loxsystem.
Methods 14, 381–392.
Scharenberg, A. M., El Hillal, O., Fru-
man, D. A., Beitz, L. O., Li, Z.,
Lin, S., Gout, I., Cantley, L. C.,
Rawlings, D. J., and Kinet, J. P.
(1998). Phosphatidylinositol-3,4,5-
trisphosphate (PtdIns-3,4,5-P3)/Tec
kinase-dependent calcium signaling
pathway:atargetforSHIP-mediated
inhibitory signals. EMBO J. 17,
1961–1972.
Shim,E.K.,Moon,C.S.,Lee,G.Y.,Ha,Y.
J., Chae, S. K., and Lee, J. R. (2004).
Association of the Src homology 2
domain-containing leukocyte phos-
phoprotein of 76 kD (SLP-76) with
thep85subunitof phosphoinositide
3-kinase. FEBS Lett. 575, 35–40.
Shim,M.S.,andKwon,Y.J.(2010).Efﬁ-
cient and targeted delivery of siRNA
in vivo. FEBS J. 277, 4814–4827.
Sieh, M., Batzer,A., Schlessinger, J., and
Weiss, A. (1994). GRB2 and phos-
pholipaseCγ1associatewitha36-to
38-kilodalton phosphotyrosine pro-
teinafterT-cellreceptorstimulation.
Mol. Cell Biol. 14, 4435–4442.
Simeoni, L., Lindquist, J. A., Smida, M.,
Witte, V., Arndt, B., and Schraven,
B. (2008). Control of lympho-
cyte development and activation by
negative regulatory transmembrane
adapterproteins.Immunol.Rev.224,
215–228.
Smith,S. J.,Ying,S.,Meng,Q.,Sullivan,
M. H.,Barkans,J.,Kon,O. M.,Sihra,
B., Larché, M., Levi-Schaffer, F., and
Kay,A. B. (2000). Blood eosinophils
from atopic donors express messen-
ger RNA for the α, β, and γ sub-
units of the high-afﬁnity IgE recep-
tor (Fcε-RI) and intracellular, but
not cell surface,α subunit protein. J.
AllergyClin.Immunol.105,309–317.
Frontiers in Immunology | Inﬂammation January 2012 | Volume 2 | Article 95 | 10Draber et al. TRAPs in FcεRI signaling
Tamir, I., Stolpa, J. C., Helgason, C. D.,
Nakamura, K., Bruhns, P., Daeron,
M., and Cambier, J. C. (2000). The
RasGAP-binding protein p62dok is
a mediator of inhibitory FcγRIIB
signals in B cells. Immunity 12,
347–358.
Thastrup,O.,Dawson,A. P.,Scharff,O.,
Foder,B.,Cullen,P. J.,Drobak,B. K.,
Bjerrum,P.J.,Christensen,S.B.,and
Hanley, M. R. (1989). Thapsigargin,
a novel molecular probe for study-
ing intracellular calcium release
and storage. Agents Actions 27,
17–23.
Tkaczyk, C., Horejsi, V., Shoko, I.,
Draber, P., Samelson, L. E., Satterth-
waite, A. B., Nahm, D. H., Met-
calfe, D. D., and Gilﬁllan, A. M.
(2004). NTAL phosphorylation is a
pivotal link between the signaling
cascades leading to human mast cell
degranulation following kit activa-
tion and FcεRI aggregation. Blood
104, 207–214.
Trub, T., Frantz, J. D., Miyazaki, M.,
Band,H.,andShoelson,S.E.(1997).
The role of a lymphoid-restricted,
Grb2-like SH3-SH2-SH3 protein in
T cell receptor signaling. J. Biol.
Chem. 272, 894–902.
Tumová, M., Koffer, A., Šimícek, M.,
Dráberová, L., and Dráber, P.
(2010). The transmembrane adap-
tor protein NTAL signals to mast
cell cytoskeleton via the small
GTPase Rho. Eur. J. Immunol. 40,
3235–3245.
Volná, P., Lebduška, P., Dráberová, L.,
Šímová, S., Heneberg, P., Boubelík,
M., Bugajev, V., Malissen, B., Wil-
son, B. S., Horejší, V., Malis-
sen, M., and Dráber, P. (2004).
Negative regulation of mast cell sig-
naling and function by the adap-
tor LAB/NTAL. J. Exp. Med. 200,
1001–1013.
Wang, B., Rieger, A., Kilgus, O., Ochiai,
K., Maurer, D., Fodinger, D., Kinet,
J. P., and Stingl, G. (1992). Epider-
mal Langerhans cells from normal
humanskinbindmonomericIgEvia
FcεRI. J. Exp. Med. 175, 1353–1365.
Weber, J. R., Ørstavik, S., Torgersen,
K. M., Danbolt, N. C., Berg, S. F.,
Ryan, J. C., Taskén, K., Imboden, J.
B., and Vaage, J. T. (1998). Mole-
cular cloning of the cDNA encod-
ingpp36,atyrosine-phosphorylated
adaptorproteinselectivelyexpressed
by T cells and natural killer cells. J.
Exp. Med. 187, 1157–1161.
Wilson, B. S., Pfeiffer, J. R., and
Oliver, J. M. (2002). FcεRI signal-
ing observed from the inside of the
mast cell membrane. Mol. Immunol.
38, 1259–1268.
Wilson, B. S., Steinberg, S. L., Lie-
derman, K., Pfeiffer, J. R., Survi-
ladze, Z., Zhang, J., Samelson, L.
E., Yang, L. H., Kotula, P. G., and
Oliver, J. M. (2004). Markers for
detergent-resistantlipidraftsoccupy
distinct and dynamic domains in
nativemembranes.Mol.Biol.Cell 15,
2580–2592.
Yablonski,D.,Kadlecek,T.,andWeiss,A.
(2001). Identiﬁcation of a phospho-
lipase C-γ1 (PLC-γ1) SH3 domain-
binding site in SLP-76 required for
T-cell receptor-mediated activation
of PLC-γ1 and NFAT. Mol. Cell Biol.
21, 4208–4218.
Yamasaki, S., Ishikawa, E., Sakuma, M.,
Kanagawa, O., Cheng, A. M., Malis-
sen, B., and Saito, T. (2007). LAT
and NTAL mediate immunoglobu-
lin E-induced sustained extracellu-
larsignal-regulatedkinaseactivation
critical for mast cell survival. Mol.
Cell Biol. 27, 4406–4415.
Yamashita, T., Mao, S.-Y., and Met-
zger, H. (1994). Aggregation of
the high-afﬁnity IgE receptor and
enhanced activity of p53/p56lyn
protein-tyrosine kinase. Proc. Natl.
Acad. Sci. U.S.A. 91, 11251–11255.
Zhang, W., Sloan-Lancaster, J., Kitchen,
J., Trible, R. P., and Samelson, L.
E. (1998a). LAT: the ZAP-70 tyro-
sine kinase substrate that links T cell
receptor to cellular activation. Cell
92, 83–92.
Zhang, W., Trible, R. P., and Samel-
son, L. E. (1998b). LAT palmitoyla-
tion: its essential role in membrane
microdomain targeting and tyro-
sine phosphorylation during T cell
activation. Immunity 9, 239–246.
Zhang,W.,Sommers,C.L.,Burshtyn,D.
N., Stebbins, C. C., DeJarnette, J. B.,
Trible,R.P.,Grinberg,A.,Tsay,H.C.,
Jacobs, H. M., Kessler, C. M., Long,
E. O., Love, P. E., and Samelson, L.
E. (1999). Essential role of LAT in
T cell development. Immunity 10,
323–332.
Zhu, M., Janssen, E., Leung, K.,
and Zhang, W. (2002). Molecular
cloning of a novel gene encoding a
membrane-associated adaptor pro-
tein (LAX) in lymphocyte signaling.
J. Biol. Chem. 277, 46151–46158.
Zhu, M., Janssen, E., and Zhang, W.
(2003). Minimal requirement of
tyrosine residues of linker for acti-
vation of T cells in TCR signaling
and thymocyte development. J.
Immunol. 170, 325–333.
Zhu,M.,Liu,Y.,Koonpaew,S.,Granillo,
O., and Zhang, W. (2004). Positive
and negative regulation of FcεRI-
mediated signaling by adaptor pro-
tein LAB/NTAL. J. Exp. Med. 200,
991–1000.
Zhu, M., Rhee, I., Liu, Y., and Zhang,
W. (2006). Negative regulation of
FcεRI-mediated signaling and mast
cell function by the adaptor pro-
tein LAX. J. Biol. Chem. 281,
18408–18413.
Conﬂict of Interest Statement: The
authors declare that the research was
conducted in the absence of any com-
mercial or ﬁnancial relationships that
could be construed as a potential con-
ﬂict of interest.
Received:31October2011;paperpending
published: 02 December 2011; accepted:
28 December 2011; published online: 11
January 2012.
Citation: Draber P, Halova I, Levi-
Schaffer F and Draberova L (2012)
Transmembrane adaptor proteins in
the high-afﬁnity IgE receptor sig-
naling. Front. Immun. 2:95. doi:
10.3389/ﬁmmu.2011.00095
This article was submitted to Frontiers in
Inﬂammation, a specialty of Frontiers in
Immunology.
Copyright © 2012 Draber, Halova, Levi-
Schaffer andDraberova.Thisisanopen-
access article distributed under the terms
of the Creative Commons Attribution
Non Commercial License, which per-
mits non-commercial use, distribution,
and reproduction in other forums, pro-
vided the original authors and source are
credited.
www.frontiersin.org January 2012 | Volume 2 | Article 95 | 11